|
![]() |
IrbesartanThis page contains recent news articles, when available, and an overview of Irbesartan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Irbesartan (when available) Irbesartan, an angiotensin II receptor antagonist similar to losartan and valsartan, is used alone or with hydrochlorothiazide to treat hypertension For the treatment of hypertension. Mechanism Of Action: Irbesartan antagonizes angiotensin II, the primary vasoactive hormone of the renin-angiotensin system, at the AT1 receptor subtype. As angiotensin II is vasoconstrictor which stimulates aldosterone secretion by the adrenal gland, blockage of its effects results in a decrease in systemic vascular resistance. News Articles on Irbesartan Can We Rely on RE-LY? - 30 Aug 2009 Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of New England Journal of Medicine (subscription) Acute coronary syndromes Randomized to a Controlled evaluation in ... - Aug 28, 2009 The goal of the trial was to evaluate treatment with irbesartan compared with enalapril (and early versus late treatment) among patients with Cardiosource Drug shortages affecting patients, new survey finds - Aug 27, 2009 ...another experienced rising blood pressure while waiting for the antihypertensive Aprovel (irbesartan), and that a shortage of the blood thinner Plavix Pharma Times Ranbaxy launches generic Losartan in Malaysia - Aug 7, 2009 ...to other similar compounds like Valsartan, Irbesartan and Telmisartan because some patients will be switched from these medicines to generic Losarta. Gerson Lehrman Group It is not universal - Aug 25, 2009 Instead of putting on the list only irbesartan and telmisartan among so-called angotensin-II-receptor blockers, all sartans—losartan, eprosartan, Business Mirror Onglyza Approved for Treatment of Type 2 Diabetes - Aug 10, 2009 Their top 3 selling products include PLAVIX® (clopidogrel bisulfate), ABILIFY® (aripiprazole), and AVAPRO®/AVALIDE® (irbesartan and MediNEWS.Direct! DoH cracks down on erring drugstores - Aug 27, 2009 Meanwhile, the 16 medicines that fall under the voluntary price reduction scheme are Telmisartan and Irbesartan (anti-hypertensives); Manila Bulletin What's going to be hot at ESC Congress 2009? - Aug 25, 2009 These include the 9000-patient ACTIVE I trial, looking at irbesartan in AF patients; the 3000-patient KYOTO Heart Study, looking at the effects of valsartan TheHeart.Org Cheaper medicines act lists medicines at reduced prices - Aug 28, 2009 There are additional 16 medicines dubbed as Government Mediated Access Price (GMAP) namely ; Telmisartan and Irbesartan for hypertension; Clopidorel for Philippine Information Agency Ligand Pharmaceuticals Inc. Q2 2009 Earnings Call Transcript - Aug 3, 2009 The high dose produced a statistically significant greater reduction in blood pressure than the active comparator, irbesartan which was tested at its Seeking Alpha Cheap medicines law registers 90% compliance - Aug 19, 2009 These are telmisartan and irbesartan, which are antihypertensive drugs; the anti-thrombotic drug clopidogrel; the anti-diabetic drug gliclazide; Inquirer.net Take drug price plaints to health centers - Aug 16, 2009 Medicines now under price control include telmisartan and irbesartan, which are antihypertensive drugs; the anti-thrombotic drug clopidogrel; Inquirer.net Diagnosis and management of hypertension in advanced renal cell ... - Aug 16, 2009 Normal BP was ensured prior to sunitinib initiation with the successive use of hydrochlorothiazide + irbesartan, nebivolol, amlodipine. UroToday Hospitals and pharmacies won't go bankrupt with cheaper meds law - CHO - Aug 17, 2009 Medicines now under price control include telmisartan and irbesartan, which are hypertensive drugs; the antithrombotic drug clopidogrel; the antidiabetic Philippine Information Agency Un congrès 2009 sous le signe de la prévention - Aug 25, 2009 ...une hypertension non contrôlée et des facteurs de risque et l'étude ACTIVE I celui de l'irbesartan dans la FA (l'étude compare l'irbesartan au placebo). theheart.org/fr Какво да очакваме от тазгодишниÑ? конгреÑ? по кардиологиÑ? на ECS в ... - Aug 29, 2009 Тук идват проучването ACTIVE I, анализиращо ефекта на irbesartan върху пациенти Ñ? предÑ?ърдно мъждене; KYOTO Heart Study, изÑ?ледващо ефектите на valsartan DoctorBG.com Mga 'di magbababa sa presyo ng gamot dapat daw parusahan - Aug 21, 2009 Nagboluntaryo naman ang kumpanya ng gamot na ibaba ang presyo ng kanilang mga produkto na telmisartan at irbesartan na antihypertensive drugs; GMA news.tv Magas vérnyomás ellen: az Angiotenzin II-receptor blokkolók működése - Aug 25, 2009 Irbesartan: ez a legjobban hasznosuló származék, kis mennyiség is elég belÅ‘le. Candesartan: vérnyomáscsökkentÅ‘ hatása ellenére növeli az agy vérellátását, WEBBeteg æ²™å?¦ç±»è?¯ç‰©é”€å”®å‡?å°‘70亿美元 é?¢ä¸´è¢«ä»¿ä¹‹ç—› - Aug 4, 2009 ...之å?Žï¼ŒATIIRaç±»è?¯è¯žç”Ÿäº†è¯¸å¦‚诺å?Žå…¬å?¸çš„代文(缬沙å?¦ã€?Diovan)ã€?默沙东公å?¸çš„ç§‘ç´ äºšï¼ˆæ°¯æ²™å?¦ã€?Cozaar)和赛诺è?²-安万特公å?¸çš„厄è´?æ²™å?¦ï¼ˆIrbesartanã€?Avapro)ç‰é”€å”® 中国食品商务网 æ²™å?¦ç±»è?¯ç‰©é”€å”®å‡?å°‘70亿美元 é?¢ä¸´è¢«ä»¿ - Aug 3, 2009 ...之å?Žï¼ŒATIIRaç±»è?¯è¯žç”Ÿäº†è¯¸å¦‚诺å?Žå…¬å?¸çš„代文(缬沙å?¦ã€?Diovan)ã€?默沙东公å?¸çš„ç§‘ç´ äºšï¼ˆæ°¯æ²™å?¦ã€?Cozaar)和赛诺è?²-安万特公å?¸çš„厄è´?æ²™å?¦ï¼ˆIrbesartanã€?Avapro)ç‰é”€å”® 慧聪网 Countdown to drug price ceiling list as firms offer alternative - 13 Jul 2009 The 22 drugs are: Amlodipine, Telmisartan, Irbesartan, Clopidogrel, Atovarsitatin, Gliclazide, Piperacillin, Tazobactam, Ciprofloxacin, Azithromycin, BusinessWorld Online Losartan counteracts the hyper-reactivity to angiotensin II and ... - Jun 22, 2009 AT-II contracture was similarly reduced in all groups by AT-II receptor antagonists, irbesartan or irbesartan plus PD123319. HA-1077 (10 microM), 7thSpace Interactive (press release) Rasilez - Japanese Ministry of Health approves Rasilez®, a first ... - Jul 7, 2009 Blood Pressure Reduction Following A Simulated Missed Dose Of Aliskiren, Irbesartan, or Ramipril: A Comparative Ambulatory Blood Pressure Monitoring Study. Ad-Hoc-News (Pressemitteilung) КомбинациÑ? аÑ?пирина и клопидогрелÑ? более Ñ?ффективно Ñ?нижает ... - Jun 23, 2009 Ð’ иÑ?Ñ?ледовании Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE) оценивалаÑ?ÑŒ Ñ?ффективноÑ?ть двойной Medicus Amicus Absurdistan zvaný Kategorizácia liekov. - Jul 9, 2009 Napriek tomu naÄ?alej zostávajú v platnosti preskripÄ?né obmedzenia Å¡pecialistov, ktorà majú v súÄ?asnosti k dispozÃcii irbesartan, candesartan, telmisartan, SME.sk ノãƒ?ルティスã€?ç›´æŽ¥çš„ãƒ¬ãƒ‹ãƒ³é˜»å®³å‰¤ï¼ˆï¼¤ï¼²ï¼©ï¼‰ã€Œãƒ©ã‚¸ãƒ¬ã‚¹éŒ ï¼‘ï¼•ï¼?ï½?g ... - Jul 7, 2009 ...ï¼ï½‰ï½“sed Dï½?se Of Aliskiren, Irbesï½?ï½’ï½”ï½?n, ï½?ï½’ ï¼²ï½?ï½?iï½?ril: A ï¼£ï½?ï½?ï½?ï½?ï½’ï½?tive Aï½?bulï½?ï½”ï½?ï½’ï½™ Blï½?ï½?d 日本経済新聞 (プレスリリース) Plavix(R) Plus Aspirin More Effective Than Aspirin Alone in ... - Mar 31, 2009 0.2% per year, RR=1.37, p=NS) ACTIVE (Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events) is a comprehensive program FOXBusiness Clopidogrel plus aspirin decreases stroke risk in patients with AF ... - Apr 14, 2009 In the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE)-A, 7554 patients with documented AF and with at Modern Medicine ACTIVE (Atrial Fibrillation Clopidogrel Trial With Irbesartan for ... - Mar 31, 2009 études distinctes : ACTIVE-W, ACTIVE-A et ACTIVE-I. Les études ACTIVE-A et W l'association Plavix(r)-aspirine. Aucune différence statistiquement deux Zonebourse.com Dans la FA, ACTIVE-A montre qu'à défaut d'AVK, il faut associer le ... - Apr 3, 2009 Orlando, FL, E.-U. — Après l'étude ACTIVE-W (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events), publiée en 2006 [1], theheart.org/fr 시오노기 í•ë¹„ë§Œì œ 日서ë?„ ì œí’ˆí™” - Mar 30, 2009 ...시오노기는 ì£¼ë ¥ì œí’ˆì?¸ ê³ ì§€í˜ˆì¦? ì¹˜ë£Œì œ 'í?¬ë ˆìŠ¤í† '(Crestor, rosuvastatin)와 ê³ í˜ˆì••ì¹˜ë£Œì œ 'ì?´ë² 탄'(Irbetan, irbesartan)ê³¼ ê°™ì?€ ìƒ?활습관병분야로 분류ë?˜ëŠ” í•비만 디지틀보사 플ë?¼ë¹…스ì—? 아스피린 병용 뇌졸중ì—?ë§Œ 효과 - Apr 14, 2009 ...ìž„ìƒ?시험ì?¸ACTIVE A (Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events Aspirin) 결과를 ë°œí‘œí•˜ê³ ì?´ê°™ì?´ ê²°ë¡ ë‚´ë ¸ë‹¤. 메디칼트리뷴 í˜ˆì••ê°•í•˜ì œ 등 ì?˜ì•½í’ˆ 120ê°œ 15ì?¼ë¶€í„° ì‹ ê·œ 보험등재 - Apr 5, 2009 ...ì?˜ ‘ë?™í™”ì?´ë² ì‚¬íƒ„ì •150mg(irbesartan)’, ë³´ëžŒì œì•½ì?˜ ‘í…?ì‹œì•„ì •15/25mg(moexipril HCl), 한êµí™”ì?´ìž?ì œì•½ì?˜ ‘노바스í?¬ì •10mg(amlodipine)’ 등 ì´? 16개가 추가ë??다. 헬스코리아뉴스 [ACC 2009]ACTIVE-A:Clopidogrel與阿斯匹é?ˆé™?低心房纖ç¶é¡«å‹•之心血管事件 - Apr 3, 2009 ...在「Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE)ã€?試驗計畫ä¸ï¼Œå¿ƒæˆ¿çº–ç¶é¡«å‹•且有一個以上其他ä¸é¢¨é¢¨éšªå› ç´ ä¹‹ 臺灣新浪網 Treatment With Amiodarone to Prevent Atrial Fibrillation - Mar 10, 2009 Patients treated with amiodarone plus irbesartan may have a lower rate of recurrence of atrial fibrillation than patients treated with amiodarone alone. Journal of American Medical Association (subscription) Drug majors put on bid alert - Mar 13, 2009 The two firms already have a partnership for the antithrombotic Plavix (clopidogrel) and the antihypertensive Avapro (irbesartan). "Overall, the most likely CITY A.M. Office management of patients with diastolic heart failure - Mar 4, 2009 A smaller randomized trial (n = 151) comparing the addition of irbesartan to standard therapy with the use of standard therapy alone found no benefit in CMAJ Irbesartan nie poprawiÅ‚ rokowania u chorych z niewydolnoÅ›ciÄ… serca ... - Mar 9, 2009 I: irbesartan po poczÄ…tkowo 75 mg 1 x dz., dawkÄ™ zwiÄ™kszano do 300 mg 1 x dz. w ciÄ…gu 2-4 tygodni Chorzy w obu grupach otrzymywali ponadto: diuretyki (na Medycyna Praktyczna Scompenso cardiaco con frazione d’eiezione preservata: Aprovel non ... - Mar 3, 2009 I Ricercatori dello studio I-PRESERVE hanno studiato gli effetti dell’Irbesartan ( Aprovel, Karvea ) nei pazienti con questa sindrome. XagenaSalute Sanofi-Aventis fronteggia la crisi - Feb 24, 2009 ...insulina glargine (+27,7%), docetaxel (+13,2%), enoxaparina sodica (+10,6%), clopidogrel bisolfato (+10,5%), irbesartan (+14,2%) e dei vaccini (+9,6%). Pharma Marketing Ligand drug reduces hypertension in midstage study - Feb 2, 2009 The drug was given in either 200-milligram, 400-milligram, or 800-milligram doses and compared with placebo or 300-milligram doses of irbesartan, Forbes, Beta-blocker benefit questioned in heart failure with preserved ... - Jan 9, 2009 The I-PRESERVE trial, as recently reported by heartwire, found no effect on mortality or CV events from the angiotensin-receptor blocker irbesartan (Avapro, TheHeart.Org, ИрбеÑ?артан при Ñ?ердечной недоÑ?таточноÑ?ти Ñ? Ñ?охранной Ñ?иÑ?толичеÑ?кой ... - Feb 2, 2009 Ð’ Ñ?той Ñ?вÑ?зи было проведено крупное рандомизированное двойное Ñ?лепое плацебо-контролируемое иÑ?пытание Irbesartan in Heart Failure with Preserved Ejection Medicus Amicus, Casi un millar de nuevos EFG financiados el año pasado - Jan 11, 2009 ...de uso hospitalario), ketorolaco trometanol (para dolor leve o moderado de uso hospitalario) y prednisona e irbesartan (de dispensación en farmacias). Correo Farmacéutico, Irbesartan in Patients With Heart Failure and Preserved Ejection ... - Dec 3, 2008 Study Question: What are the effects of renin-angiotensin-aldosterone system (RAAS) blockade with irbesartan in patients with heart failure and preserved Cardiosource, Irbesartan in Patients with Heart Failure and Preserved Ejection ... - Dec 3, 2008 Therefore, we studied the effects of irbesartan in patients with this syndrome. Methods We enrolled 4128 patients who were at least 60 years of age and had New England Journal of Medicine (subscription), Treatment Fails To Improve Common Form Of Heart Failure, Study Finds - Dec 13, 2008 One group received 300 milligrams of irbesartan, an anti-hypertensive medication marketed as AvaproTM. The other group was given a placebo. Science Daily (press release) B-MS to reduce workforce by an additional 10% - Dec 17, 2008 Plavix (clopidogrel), and other big earners such as the antipsychotic Abilify (aripiprazole) and the antihypertensive Avapro/Avalide (irbesartan). Pharma Times, New heart research path opens - Dec 15, 2008 Irbesartan appeared ideal because the drug reduces the hardening of tissue and showed promising results in heart failure patients whose hearts didn't pump Charleston Post Courier, Irbesartan in scompenso a frazione di eiezione preservata non ... - Dec 6, 2008 ...in pazienti con insufficienza cardiaca e frazione di eiezione ventricolare sinistra preservata irbesartan non riduce significativamente gli eventi Pillole.org, BMS, ì œì¡°ì‹œì„¤ 50% í??ì‡ -추가 êµ¬ì¡°ì¡°ì •ë?„ 단행 - Dec 19, 2008 ...ì œí’ˆì?¸ í• ì?‘ê³ ì œ 프ë?¼ë¹…스(clopidogrel), ì •ì‹ ë³‘ 치료약 ì—?빌리파ì?´ (aripiprazole) ë°? ê³ í˜ˆì•• ì¹˜ë£Œì œ 아바프로/ì•„ë°”ë?¼ì?´ë“œ(irbesartan) 등ì?˜ 특허가 만료ë?œë‹¤. 메디í?¬ë‰´ìФ, Brand Names/Synonyms: Irbesartan is also known by the following brand names and/or synonymsAvalide; Avapro; CHEMBANK1635; Irbesarran; Irbesartan; Irbesartan [Usan:Inn]; Lrbesartan Drug Category: Irbesartan is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA04 Dosage Forms: Oral tablets Absorption: 60-80% Interactions: -->Interactions for Irbesartan: No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP 2C9 substrates/inhibitors sulphenazole, tolbutamide and nifedipine. However, in clinical studies the consequences of concomitant irbesartan on the pharmacodynamics of warfarin were negligible. Based on in vitro data, no interaction would be expected with drugs whose metabolism is dependent upon cytochrome P450 isozymes 1A1, 1A2,2A6,2B6,2D6,2E1,or 3A4. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.
Chemical IUPAC Name: 3-butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |